Study guide
10.1 Ischemic & Hemorrhagic Stroke
AACN CCRN Adult
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Strategy
1.1 Exam Facts, Format & the Synergy Model Blueprint 1.2 How to Study & Test-Taking Strategy
2 Cardiovascular I — Hemodynamics & Shock
2.1 Hemodynamic Monitoring & Values 2.2 Shock States 2.3 Vasoactive & Inotropic Pharmacology
3 Cardiovascular II — ACS, Heart Failure & Dysrhythmias
3.1 Acute Coronary Syndrome & Myocardial Infarction 3.2 Heart Failure & Mechanical Circulatory Support 3.3 Dysrhythmias, ECG & ACLS
4 Respiratory I -- Failure, ABGs & Acute Conditions
4.1 Respiratory Failure & ABG Interpretation 4.2 Acute Respiratory Distress Syndrome (ARDS) 4.3 Pulmonary Embolism, Pneumothorax, COPD & Asthma
5 Respiratory II — Mechanical Ventilation
5.1 Ventilator Modes & Settings 5.2 Weaning, Airway & Ventilator Complications
6 Endocrine Emergencies
6.1 Glycemic Emergencies 6.2 DI, SIADH, Thyroid & Adrenal Crises
7 Renal & Genitourinary
7.1 Acute Kidney Injury, Electrolytes & Acid-Base 7.2 Renal Replacement Therapy
8 Gastrointestinal
8.1 GI Bleeding & Acute Hepatic Failure 8.2 Pancreatitis, Acute Abdomen, Bowel Ischemia & Nutrition
9 Hematology, Immunology & Integumentary
9.1 Coagulopathies & Transfusion Therapy 9.2 Immunocompromise & Oncologic Emergencies 9.3 Integumentary - Wounds & Pressure Injuries
10 Neurological I — Stroke, TBI & ICP
10.1 Ischemic & Hemorrhagic Stroke 10.2 Traumatic Brain Injury & ICP Management 10.3 Seizures, Status Epilepticus & Neuromonitoring
11 Neurological II & Musculoskeletal
11.1 Spinal Cord Injury & Neuromuscular Emergencies 11.2 Encephalopathy, Coma & Brain Death 11.3 Musculoskeletal
12 Behavioral & Psychosocial
12.1 Delirium, Agitation, Sedation & Pain 12.2 Substance Withdrawal, Psychiatric Emergencies & Patient Safety
13 Multisystem I — Sepsis & MODS
13.1 Sepsis & Septic Shock 13.2 Multi-Organ Dysfunction Syndrome 13.3 Resuscitation Priorities & Rapid Response
14 Multisystem II — Trauma, Burns & Toxicology
14.1 Trauma & Burns 14.2 Toxicology, Anaphylaxis & Temperature Emergencies
15 Synergy Model, Advocacy & Caring
15.1 The AACN Synergy Model 15.2 Advocacy & Moral Agency 15.3 Caring Practices
16 Collaboration, Systems Thinking & Diversity
16.1 Collaboration & Interdisciplinary Teamwork 16.2 Systems Thinking 16.3 Response to Diversity & Facilitation of Learning
17 Clinical Inquiry, Ethics & End-of-Life
17.1 Clinical Inquiry & Evidence-Based Practice 17.2 Ethical/Legal Issues, End-of-Life & Goals of Care
10.1 Ischemic & Hemorrhagic Stroke
Key Takeaways Explain This Topic AI
IV alteplase (tPA) is given within 4.5 hours of last-known-well; BP must be below 185/110 before treatment and below 180/105 for 24 hours after.
Alteplase dose is 0.9 mg/kg (max 90 mg): 10% bolus, remainder over 60 minutes; hemorrhage on CT is an absolute contraindication.
In ischemic stroke NOT receiving tPA, use permissive hypertension and treat only if BP exceeds ~220/120 mmHg.
Aneurysmal SAH vasospasm peaks days 4-14; oral nimodipine 60 mg every 4 hours for 21 days improves outcomes.
Mechanical thrombectomy treats large-vessel occlusion within 6 hours, extended to 24 hours with favorable perfusion imaging.
Last updated: July 2026
Two Mechanisms, Opposite Treatments
Stroke is an acute neurologic deficit caused by disrupted cerebral blood flow. About 87% of strokes are ischemic (arterial occlusion from a thrombus or embolus) and roughly 13% are hemorrhagic , split between intracerebral hemorrhage (ICH, ~10%) and subarachnoid hemorrhage (SAH, ~3%) . The CCRN tests your ability to separate these two on the emergent noncontrast head CT, because the treatments are diametrically opposed: an ischemic stroke may receive a clot-dissolving drug, while giving that same drug into a bleed is catastrophic. Time is brain — roughly 1.9 million neurons die each minute of large-vessel ischemia, which is why door-to-needle and door-to-groin times drive stroke systems of care.
Ischemic Stroke: Thrombolysis
IV thrombolysis with alteplase (tissue plasminogen activator, tPA) is indicated within 4.5 hours of symptom onset (measured from last-known-well time, not arrival); tenecteplase (0.25 mg/kg) is an increasingly used single-bolus alternative. Alteplase is dosed at 0.9 mg/kg (maximum 90 mg) : 10% given as a bolus, the remainder infused over 60 minutes. Before administration, blood pressure must be below 185/110 mmHg — use IV labetalol or nicardipine to get there. After alteplase, keep BP below 180/105 for 24 hours and withhold anticoagulants and antiplatelets for 24 hours while watching for the feared complication: symptomatic intracranial hemorrhage (sudden headache, vomiting, acute neuro decline, BP spike).
Absolute contraindications include any hemorrhage on CT, active internal bleeding, recent intracranial/spinal surgery or head trauma within 3 months, platelet count <100,000, INR >1.7, glucose <50 mg/dL, and BP that cannot be lowered below 185/110. The 3-4.5-hour extended window adds relative exclusions (age >80, oral anticoagulant use, prior stroke plus diabetes, NIHSS >25).
NIHSS and Mechanical Thrombectomy
The National Institutes of Health Stroke Scale (NIHSS) scores deficits from 0 to 42 — higher is worse, and a score of 6 or more raises suspicion of a large-vessel occlusion (LVO) . Mechanical thrombectomy (endovascular clot retrieval) is the treatment for LVO of the internal carotid or proximal middle cerebral artery. The standard window is within 6 hours , extended to 24 hours in selected patients with a favorable perfusion-imaging mismatch (DAWN and DEFUSE-3 criteria). Thrombectomy and tPA are complementary; an eligible patient often receives both.
Blood Pressure: Permissive Hypertension
When a patient is not a thrombolysis candidate, permissive hypertension protects the ischemic penumbra. Antihypertensives are generally withheld unless BP exceeds ~220/120 mmHg (or there is another indication such as aortic dissection or acute MI). Lowering pressure aggressively can extend the infarct — a classic CCRN trap.
- Stroke scenario Blood pressure target
- Ischemic, receiving tPA <185/110 before; <180/105 x 24 h after
- Ischemic, NOT receiving tPA Permissive; treat only if >220/120
- Intracerebral hemorrhage (ICH) SBP ~140 (range 130-150)
- Aneurysmal SAH, aneurysm unsecured SBP <160
- Rapid Recognition and Localization
Bedside screening uses BE-FAST — B alance, E yes (sudden visual loss), F ace droop, A rm drift, S peech change, T ime — to trigger a stroke alert. Localizing the deficit predicts the vessel: dominant (usually left) hemisphere strokes produce aphasia with right-sided weakness, nondominant strokes cause neglect and left-sided weakness, and posterior-circulation strokes cause vertigo, diplopia, dysarthria, and ataxia. A hyperdense middle cerebral artery sign on CT hints at a proximal clot. The nurse documents the exact last-known-well time , checks fingerstick glucose (hypoglycemia is a common stroke mimic), draws coagulation labs, and keeps the patient NPO until a swallow screen is passed. During and after alteplase, perform neuro checks and vital signs every 15 minutes for 2 hours , then every 30 minutes — a sudden headache, nausea, acute hypertension, or declining exam suggests symptomatic hemorrhage, so you stop the infusion and obtain an emergent CT.
Hemorrhagic Stroke
ICH management centers on blood-pressure control and reversing coagulopathy. Target a systolic BP around 140 mmHg (acceptable ~130-150) with a titratable agent such as nicardipine, and reverse anticoagulation urgently — 4-factor PCC plus vitamin K for warfarin, andexanet or idarucizumab for DOACs, protamine for heparin. Watch for hematoma expansion, hydrocephalus, and rising intracranial pressure.
Subarachnoid Hemorrhage
Aneurysmal SAH classically presents as a sudden thunderclap or worst headache of my life , often with meningismus and photophobia. Severity is graded by the Hunt-Hess scale :
- Hunt-Hess grade Clinical picture
- I Asymptomatic or mild headache, slight nuchal rigidity
- II Moderate-severe headache, nuchal rigidity, no deficit except CN palsy
- III Drowsy/confused, mild focal deficit
- IV Stupor, moderate-severe hemiparesis
- V Deep coma, decerebrate posturing
Before the aneurysm is secured (clipped or coiled), keep SBP <160 mmHg to reduce rebleeding , the deadliest early complication (highest risk in the first 24 hours). Three complications drive nursing surveillance: rebleeding; cerebral vasospasm / delayed cerebral ischemia (DCI) , which peaks days 4-14 and is countered with oral nimodipine 60 mg every 4 hours for 21 days (it reduces DCI harm rather than abolishing angiographic vasospasm; once the aneurysm is secured, symptomatic vasospasm is treated with euvolemia and induced hypertension); and hyponatremia from cerebral salt wasting (hypovolemic) or SIADH (euvolemic) — avoid hypotonic fluids. Maintain the airway (GCS 8 or less means intubate), perform frequent NIHSS/neuro checks, keep glucose 140-180, ensure normothermia, and screen for dysphagia before any oral intake.